BF Biosciences Limited (PSX:BFBIO)

Market Cap	14.76B
Revenue (ttm)	4.96B
Net Income (ttm)	391.70M
Shares Out	88.33M
EPS (ttm)	5.24
PE Ratio	31.86
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	261,333
Average Volume	608,460
Open	171.88
Previous Close	169.17
Day's Range	168.56 - 171.88
52-Week Range	76.06 - 253.97
Beta	n/a
RSI	45.59
Earnings Date	Oct 24, 2025

About BF Biosciences

BF Biosciences Limited, a diversified biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products. It offers a range of products in the areas of nephrology, cardiology, gastroenterology, diabetes, oncology, anti-viral, and hepatology. The company was incorporated in 2006 and is headquartered in Raiwind, Pakistan. BF Biosciences Limited is a subsidiary of Ferozsons Laboratories Limited.

• Industry: Pharmaceutical Preparations
• Founded: 2006
• Country: Pakistan
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: BFBIO

Financial Performance

In 2024, BF Biosciences's revenue was 3.66 billion, an increase of 102.19% compared to the previous year's 1.81 billion. Earnings were 385.41 million, an increase of 158.57%.